Submit your email to push it up the queue
Daiichi Sankyo Belgium N.V.-S.A., a prominent subsidiary of the global pharmaceutical company Daiichi Sankyo, is headquartered in Belgium and operates extensively across Europe. Founded in 2005, the company has established itself in the pharmaceutical industry, focusing on innovative medicines in areas such as oncology, cardiovascular diseases, and vaccines. Daiichi Sankyo is renowned for its commitment to research and development, with a portfolio that includes unique therapeutic solutions designed to address unmet medical needs. The company’s advanced drug delivery systems and targeted therapies set it apart in a competitive market. With a strong market position, Daiichi Sankyo Belgium has achieved significant milestones, contributing to the advancement of healthcare in the region and beyond.
How does Daiichi Sankyo Belgium N.V.-S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Daiichi Sankyo Belgium N.V.-S.A.'s score of 58 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Daiichi Sankyo Belgium N.V.-S.A. currently does not report specific carbon emissions data, as no emissions figures are available. However, the company is part of a broader corporate family that includes Daiichi Sankyo Company, Limited, which has established significant climate commitments and reduction initiatives. As a current subsidiary, Daiichi Sankyo Belgium N.V.-S.A. inherits its climate strategies and targets from Daiichi Sankyo Company, Limited, which is committed to reducing its carbon footprint through various initiatives. These initiatives include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which aim to enhance sustainability and reduce greenhouse gas emissions across the organisation. While specific reduction targets for Daiichi Sankyo Belgium N.V.-S.A. are not detailed, the overarching goals set by its parent company reflect a commitment to addressing climate change and minimising environmental impact. The company is aligned with industry standards and practices, focusing on sustainable operations and responsible resource management. In summary, while Daiichi Sankyo Belgium N.V.-S.A. does not provide specific emissions data, it is actively engaged in climate commitments through its affiliation with Daiichi Sankyo Company, Limited, which drives its sustainability efforts and emissions reduction strategies.
Access structured emissions data, company-specific emission factors, and source documents
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 182,519,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 290,715,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 5,704,000 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo Belgium N.V.-S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.